Viewing nowCombinationDualsaltan Tablet 40/10mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CTC Bio, Co., Ltd.

MFDS item code 201605742 · Approved 2016.09.30 · Insurance code 669502110
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy using either telmisartan or amlodipine. This drug helps to lower blood pressure more effectively and reduce the risk of complications due to hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to this medication may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medication have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued as soon as possible. This medication should not be administered to patients who are allergic to the active ingredient or related components, pregnant women or women of childbearing potential, nursing mothers, patients with obstructive biliary disease, severe liver impairment, patients with a narrowed left ventricular outflow tract in the heart, severe hypotension, patients in shock, unstable heart failure after acute myocardial infarction, patients allergic to excipients, and patients with diabetes or moderate to severe renal impairment. Patients with specific diseases, such as primary aldosteronism, aortic stenosis, mitral stenosis, liver disease, gastrointestinal disorders, renovascular hypertension, patients undergoing dialysis, and the elderly, require special caution when using this medication. The most common side effects experienced during treatment are dizziness and peripheral edema. Serious side effects such as fainting may occur infrequently, so if any abnormal symptoms appear, medical consultation should be sought immediately. This medication should not be initiated during pregnancy, and if planning for pregnancy, it is advisable to switch to other antihypertensives that have confirmed safety. Because this medication lowers blood pressure, hypotensive symptoms may occur, especially in patients who are fluid-depleted, and they should consult their doctor before taking the medication. There is a risk of elevated potassium levels in the blood, so caution is needed when taking potassium supplements or medications containing potassium. Patients with impaired renal function should have regular blood tests to monitor renal function and electrolyte status. Patients with heart disease should be cautious as myocardial infarction or angina symptoms may worsen after taking this medication. This medication can cause drowsiness or dizziness; therefore, caution is needed when driving or operating dangerous machinery. There may be drug interactions when combined with other medications, so if you are taking any other drugs, you must inform your healthcare provider. Exceeding the prescribed dose can lead to serious side effects such as hypotension, arrhythmias, and acute renal failure; therefore, it is essential to visit a healthcare facility immediately. This medication is not recommended for children or adolescents under 18 years of age, as its safety and efficacy have not been sufficiently established. Elderly patients may respond more sensitively to this medication, so they should start at a lower dose, gradually increasing it.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a tightly closed container that blocks light. It should be kept at room temperature, between 1°C and 30°C.
Biconvex oval double tablets, white and light blue in color
30 tablets/PTP [30 tablets (10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CTC Bio, Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.